Industry Reports

ICON reports revenues of $225 million up 2% on...

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, reported its financial results for the third quarter ended...

Pfizer Entering into a partnership with Laboratorio Teuto Brasileiro...

Pfizer Inc. announced that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop...

Genzyme Reports Financial Results for the Third-quarter revenue was...

Genzyme Corp. reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection). Patients in the United States began returning to normal dosing...

Teva to Report Third Quarter 2010 Financial Results on...

Teva Pharmaceutical Industries Ltd. announced that it will release its third quarter 2010 financial results on Tuesday, November 2, 2010. Teva will...

Cephalon Reports Record Sales – Quaterly sales increased 32%...

Cephalon, Inc. reported second quarter 2010 sales of $712.4 million, a 32 percent increase compared to sales of $539.0 million for the second quarter 2009....

Ranbaxy Achieves USD 1 Billion Revenue

The Board of Directors of Ranbaxy Laboratories Limited (RLL) at their meeting held today, took on record the unaudited results for the quarter ended June...

King Pharmaceuticals, Inc announced total revenue for the second...

King Pharmaceuticals, Inc.announced that total revenue for the second quarter ended June 30, 2010 equaled $371 million compared to $445 million in the second quarter...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read